baber/WOPTO huggingface dataset:
Patent CY-1114847-T1 (CY)
Title: ΔΙ- ΚΑΙ ΠΟΛΥΚΥΚΛΙΚΕΣ ΙΣΟΚΙΝΟΛΙΝΕΣ ΚΑΙ ΠΑΡΑΓΩΓΑ ΙΣΟΚΙΝΟΛΙΝΩΝ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ rho ΚΙΝΑΣΗΣ
Inventor: PLETTENBURG OLIVER
IPC: A61K31/472
Filed: 2013-11-25
Abstract: H εφεύρεση αναφέρεται στις δι- και πολυκυκλικές υποκατεστημένες ισοκινολίνες και ισοκινολινόνες του χημικού τύπου (Ι) όπου οι R1 έως R12 ορίζονται στην αίτηση και οι οποίες μπορούν να χρησιμοποιηθούν για την αντιμετώπιση ή/και την πρόληψη των νοσημάτων που συνδέονται με την Rhο-κινάση ή/και την μεσολαβούμενη από την Rho-κινάση φωσφορυλίωση της φωσφατάσης της ελαφριάς αλυσίδας της μυοσίνης, και στις συνθέσεις που περιέχουν τις ενώσεις αυτές.
Patent CY-1118027-T1 (CY)
Title: Μεθοδος και συσκευη για κωδικοποιηση βιντεο, και μεθοδος και συσκευη για την αποκωδικοποιηση βιντεο
Inventor: CHEN JIANIE
IPC: H04N19/112
Filed: 2016-09-21
Abstract: Παρουσιάζεται μια μέθοδος κωδικοποίησης ενός βίντεο, με τη μέθοδο να περιλαμβάνει τα ακόλουθα: διαχωρισμό μιας τρέχουσας εικόνας σε τουλάχιστον μία μέγιστη μονάδα κωδικοποίησης, προσδιορισμό ενός κωδικοποιημένου βάθους για την παραγωγή ενός τελικού αποτελέσματος κωδικοποίησης σύμφωνα με τουλάχιστον μία περιοχή διαχωρισμού που λαμβάνεται με τον διαχωρισμό μιας περιοχής της μέγιστης μονάδας κωδικοποίησης σύμφωνα με τα βάθη, με την κωδικοποίηση της τουλάχιστον μίας περιοχής διαχωρισμού, βάσει ενός βάθους που αυξάνεται σε αναλογία με τον αριθμό των φορών κατά τις οποίες η περιοχή της μέγιστης μονάδας κωδικοποίησης διαχωρίζεται, και παραγωγή των δεδομένων εικόνας που αποτελούν το τελικό αποτέλεσμα κωδικοποίησης σύμφωνα με την τουλάχιστον μία περιοχή διαχωρισμού, και κωδικοποίηση πληροφοριών σχετικά με το κωδικοποιημένο βάθος και μια κατάσταση πρόβλεψης, σύμφωνα με την τουλάχιστον μία μονάδα κωδικοποίησης.
Patent CY-1119225-T1 (CY)
Title: Αλκυλαμινικες ενωσεις και οι χρησεις τους
Inventor: BARONI SERGIO
IPC: C07D319/08
Filed: 2017-06-28
Abstract: Στο παρόν περιγράφονται ενώσεις που σχετίζονται ειδικά με τους υποδοχείς που ενεργοποιούνται από πολλαπλασιαστές υπεροξειδιοσωμάτων (PPAR) και/ή υποδοχείς επιδερμοειδούς αυξητικού παράγοντα (EGF) και τις μεθόδους παρασκευής και χρήσης αυτών.
Patent CY-1120589-T1 (CY)
Title: Συσκευη και διαδικασια ανοιγματος δοχειων που περιεχουν ετερογενη υλικα
Inventor: CHARREYRE FABIEN MICHEL ALAIN
IPC: B65B69/00
Filed: 2018-06-19
Abstract: Η εφεύρεση αφορά σε μία συσκευή (1) για το άνοιγμα των δοχείων (C) που περιλαμβάνει: - ένα περίβλημα (2) που διαθέτει μια είσοδο (3) για την εισδοχή των δοχείων (C) που είναι πάνω από την έξοδο (4), - ένα περιστρεφόμενο εργαλείο τεμαχισμού (10) που μπορεί να προκαλέσει το άνοιγμα των δοχείων (C) και που εκτείνεται μεταξύ ενός κάτω άκρου (11) και ενός πάνω άκρου (12), όπου το εν λόγω εργαλείο τεμαχισμού (10) είναι εγκατεστημένο από το πάνω άκρο του (12), ενώ το κάτω άκρο (11) του εν λόγω εργαλείου τεμαχισμού (10) είναι ελεύθερο μέσα στο εσωτερικό του εν λόγω περιβλήματος (2), - ένα μέσο μετάδοσης κίνησης (14) περιστροφής του εν λόγω εργαλείου τεμαχισμού (10), όπου η συσκευή (1) χαρακτηρίζεται από το ότι το εν λόγω εργαλείο τεμαχισμού (10) έχει μία θέση αναφοράς από την οποία μπορεί να κινείται ενώ συνεχίζει να εκτελεί την λειτουργία του ανοίγματος των δοχείων (C), όπου το εν λόγω εργαλείο τεμαχισμού (10) έχει μία φυσική τάση να επιστρέφει στην θέση του αναφοράς υπό την δράση ενός μέσου ανάκλησης (34). Ανοίγοντας τα δοχεία.
Patent CY-1121260-T1 (CY)
Title: Μεθοδος για ληψη ενος διαπιδυσιμου εκχυλισματος λευκοκυτταρων
Inventor: ESTRADA PARRA SERGIO
IPC: C07K14/52
Filed: 2018-09-25
Abstract: Η παρούσα εφεύρεση σχετίζεται με μία μέθοδο για παραγωγή ενός παράγοντα μεταφοράς. Η μέθοδος περιλαμβάνει τα ακόλουθα στάδια: κατάψυξη και απόψυξη λευκοκυττάρων περιφερικού αίματος, διαπίδυση, εφαπτομενική υπερδιήθηση, ταυτοποίηση και ποσοτικοποίηση χρησιμοποιώντας υψηλής-ανάλυσης, υγρή χρωματογραφία μοριακού αποκλεισμού, και in vitro βιολογική επαλήθευση. Το προκύπτον προϊόν είναι κατάλληλο για ιατρική χρήση.
Patent CY-1123930-T1 (CY)
Title: Συνδυασμοι fgfr και cmet αναστολεων για τη θεραπεια του καρκινου
Inventor: JOVCHEVA ELEONORA
IPC: A61K31/498
Filed: 2021-02-26
Abstract: Η εφεύρεση αναφέρεται σε έναν συνδυασμό μιας πρώτης ένωσης που επιλέγεται από Ν-(3,5-διμεθοξυφαινυλ)-Ν'-(1-μεθυλ-αιθυλ)-Ν-[3-(1-μεθυλ-1Η-πυραζολ-4-υλ) κινοξαλιν-6-υλ]αιθάνο-1,2-διαμίνη ή ένα φαρμακευτικά αποδεκτό άλας αυτής ή ένα επιδιαλυτωμένο άλας αυτής και Ν-(2-φθορο-3,5-διμεθοξυφαινυλ)-Ν-(1Η-ιμιδαζολ-2-υλομεθυλ)-3-(1-μεθυλ-1Η-πυραζολ-4-υλ)πυριδο[2,3-b]πυραζιν-6-αμίνη ή ένα φαρμακευτικά αποδεκτό άλας αυτής ή ένα επιδιαλυτωμένο άλας αυτής• και μια δεύτερη ένωση που είναι ένας αναστολέας cMet. Ο συνδυασμός προορίζεται προς χρήση στη θεραπεία μιας πολλαπλασιαστικής διαταραχής, ιδιαίτερα προς χρήση στη θεραπεία του καρκίνου. Ο αναστολέας FGFR (Ν-(3,5-διμεθοξυφαινυλ)-Ν'-(1-μεθυλαιθυλ)-Ν-[3- (1-μεθυλ-1Η-πυραζολ-4-υλο)κινοξαλιν-6-υλ]αιθάνο-1,2-διαμίνη ή ένα φαρμακευτικά αποδεκτό άλας αυτής ή ένα επιδιαλυτωμένο άλας αυτής, και η Ν-(2-φθορο-3,5-διμεθοξυφαινυλ)-Ν-(1Η-ιμιδαζολ-2-υλομεθυλ)-3-(1-μεθυλ-1Η-πυραζολ-4-υλ)πυριδο[2,3-b)]πυραζιν-6-αμίνη ή ένα φαρμακευτικά αποδεκτό άλας αυτής ή ένα επιδιαλυτωμένο άλας αυτής) και ο αναστολέας cMet μπορούν να χορηγούνται ταυτόχρονα, ξεχωριστά ή διαδοχικά. Η εφεύρεση αναφέρεται, επίσης, σε μια φαρμακευτική σύνθεση, η οποία περιλαμβάνει ένα φαρμακευτικά αποδεκτό φορέα και έναν συνδυασμό σύμφωνα με την εφεύρεση.
Patent GR-880300031-T1 (GR)
Title: Remotely controlled catheter with a retaining balloon
Inventor: MAURICE JEANMONOD
IPC: A61F2/958
Filed: 1988-05-20
Abstract: A remote controlled catheter with micro-balloon, having a head constituted by a cylindrical coil spring (2) having separated coils covered by a micro-balloon (10) and mounted coaxially at the end of a tube (1). The spring can be bent at will in order to facilitate its introduction along arteries. The user pulls on the rear of a flexible pulling member (5) the forward end of which is fastened to the upper part of the head eccentrically of the axis of the head, this element (5) passing within the tube (1). To inflate the balloon (10), fluid is introduced through a channel (11), through the tube (1), the base of the balloon (10) being fixed to the tube (1) in a sealed manner. To inject a contrast liquid within the arterial channel, this liquid is introduced by a channel (12) communicating with the space between the tube (1) and the covering (9) and is expelled through two openings (13 and 14), this latter operation being possible thanks to the fact that one of the ends of the covering (9) is sealed to the frame member (6), whereas the other end is also sealed but on the tube (1).
Patent GR-900300087-T1 (GR)
Title: Process to produce l-alpha-amino acids
Inventor: WAGNER FRITZ PROF DR
IPC: C12P13/04
Filed: 1991-07-31
Abstract: Microorganisms with the ability to cleave enantioselectively 5-substituted hydantoins to L-alpha-amino acids are cultivated in a known manner in a batch preparation. By one-time dosage of anondegradable enzyme inductor of the structure  <IMAGE>  (where R1, R2 and X are specifically defined) an increased enzyme activity combined with an increased reaction rate is achieved.
Patent HR-P20100137-T1 (HR)
Inventor: HACKET KRISTINA CLARE
IPC: A61P17/02
Filed: 2010-03-10
Abstract: Spinozin, ili njegov fiziološki prihvatljiv N-demetilirani derivat ili njegova sol, naznačen time što je namijenjen upotrebi u poticanju ubrzanog zacjeljivanja rana kod sisavca. Patent sadrži još 8 patentnih zahtjeva.
Patent HR-P20100651-T1 (HR)
Inventor: BELL ANDREW SIMON
IPC: A61K31/505
Filed: 2010-11-26
Abstract: Spoj formule (I) naznacen time stoR1 je prstenasta skupina, koju se bira izmedu RA, RB, RC i RD, od kojih je svaki izborno supstituiran s jednom ili vise skupina R7;R2 je vodik ili C1-C2 alkil; svaki od R3 i R4 je neovisno C1-C8 alkil, C2-C8 alkenil, C2-C8 alkinil- ili C3-C10 cikloalkil, od kojih je svaki izborno supstituiran s jednom ili vise skupina R8, ili RE, koji je izborno supstituiran s jednom ili vise skupina R9, ili vodik; ili -NR3R4 tvori RF, koji je izborno supstituiran s jednom ili vise skupina R10;R5 se bira izmedu -Y-CO2R15 i -Y-R16;R6, koji moze biti vezan na N1 ili N2, je C1-C6 alkil, C1-C6 halogenalkil, C2-C6 alkenil ili C2-C6 alkinil, od kojih je svaki izborno supstituiran s C1-C6 alkoksi, C1-C6 halogenalkoksi ili prstenastom skupinom koju se bira izmedu RJ, RK, RL i RM, ili R6 je RN, C3-C7 cikloalkil ili C3-C7 halogencikloalkil, od kojih je svaki izborno supstituiran s C1-C6 alkoksi ili C1-C6 halogenalkoksi, ili R6 je vodik; R7 je halogen, C1-C6 alkil, C1-C6 halogenalkil, C2-C6 alkenil, C2-C6 alkinil, C3-C10 cikloalkil, C3-C10 halogencikloalkil, fenil, OR12, OC(O)R12, NO2, NR12R13, NR12C(O)R13, NR12CO2R14, C(O)R12, CO2R12, CONR12R13 ili CN; R8 je halogen, fenil, C1-C6 alkoksifenil, OR12, OC(O)R12, NO2, NR12R13, NR12C(O)R13, NR12CO2R14, C(O)R12, CO2R12, CONR12R13, CN, C3-C6 cikloalkil, RG ili RH, od kojih su potonja dva izborno supstituirana s jednom ili vise skupina R9;R9 je C1-C6 alkil, C1-C6 halogenalkil ili CO2R12;R10 je halogen, C3-C10 cikloalkil, C3-C10 halogencikloalkil, fenil, OR12, OC(O)R12, NO2, NR12R13, NR12C(O)R13, NR12CO2R14, C(O)R12, CO2R13, CONR12R13, CN, okso, C1-C6 alkil ili C1-C6 halogenalkil, od kojih su potonja dva izborno supstituirana s R11;R11 je fenil, NR12R13 ili NR12CO2R14;svaki od R12 i R13 je neovisno vodik, C1-C6 alkil ili C1-C6 halogenalkil; R14 je C1-C6 alkil ili C1-C6 halogenalkil; R15 je vodik ili C1-C6 alkil izborno supstituiran s jednom ili vise skupina, koje se bira izmedu halogena, OH, C1-C6 alkiloksi, NH2, NH(C1-C6alkil) i N(C1-C6 alkil)2;R16 je izoster karboksilne kiseline, kojeg se bira izmedu tetrazol-5-ila, 5-trifluormetil-1,2,4-triazol-3-ila, 5-(metilsulfonil)-1,2,4-triazol-3-ila, 2,5-dihidro-5-okso-1,2,4-oksadiazol-3-ila, -SO2NHR17 i -CONHR18;R17 se bira izmedu C1-C6 alkila, fenila, -CO-(C1-C6 alkil) i -CO-fenila; R18 se bira izmedu -SO2-(C1-C6 alkil) i -SO2-fenila; svaki od RA i RJ je neovisno C3-C10 cikloalkilna ili C3-C10 cikloalkenilna skupina, od kojih svaka moze biti bilo monociklicka ili, kada je u prstenu dovoljan broj atoma, policiklicka, te koja moze biti kondenzirana bilo s (a)	monociklickim aromatskim prstenom, kojeg se bira izmedu benzenskog prstena i 5- ili 6-eroclanog heteroaromatskog prstena, koji sadrzi do tri heteroatoma, koje se bira izmedu dusika, kisika i sumpora, ili (b)	5-, 6- ili 7-eroclanim heteroaliciklickim prstenom, koji sadrzi do tri heteroatoma, koje se bira izmedu dusika, kisika i sumpora; svaki od RB i RK je neovisno fenilna ili naftilna skupina, od koji
Patent HR-P20110510-T1 (HR)
Inventor: HEIMBACH DIRK
IPC: C07D413/14
Filed: 2011-07-07
Abstract: Spojevi formule naznačeni time daA predstavlja skupinu formule gdje # je točka vezanja na piperidinski prsten, i* je točka vezanja na R2,R1 predstavlja fenil, gdje fenil može biti supstituiran sa 1 do 3 supstituenata odabranih nezavisno jedan od drugoga iz skupine koja sadrži monofluorometil, difluorometil, trifluorometil, monofluorometoksi, difluorometoksi, trifluorometoksi, monofluorometilsulfanil, difluorometilsulfanil, trifluorometilsulfanil, metilsulfonil, C1-C4-alkil, C1-C4-alkoksi, C1-C4-alkoksikarbonil i C3-C6- cikloalkil, gdje C2-C4-alkoksi može biti supstituiran sa supstituentom odabranim iz skupine koja sadrži metoksi i etoksi, igdje cikloalkil može biti supstituiran sa 1 do 3 supstituenta odabrana nezavisno jedan od drugoga iz skupine koja sadrži halogen i C1-C4- alkil, R2 predstavlja vodik, trifluorometil, aminometil, C1-C6-alkil, C2-C6-alkenil, C1- C4-alkoksikarbonil, C3-C6-cikloalkil, ciklopentenil, 4- do 6-člani heterociklil, fenil, 1,3-benzodioksolil, 5- ili 6-člani heteroaril ili piridilaminokarbonil, gdje cikloalkil, heterociklil, fenil i heteroaril mogu biti supstituirani sa 1 do 3 supstituenta odabrana nezavisno jedan od drugoga iz skupine koja sadrži halogen, cijano, amino, monofluorometil, difluorometil, trifluorometil, monofluorometoksi, difluorometoksi, trifluorometoksi, monofluorometilsulfanil, difluorometilsulfanil, trifluorometilsulfanil, C1-C4-alkil, C1-C4-alkoksi, C1-C6-alkilamino, C1-C4-alkoksikarbonilamino, C3-C6-cikloalkil, 4- do 6-člani heterociklil, fenil i 5- ili 6-člani heteroaril, gdje alkilamino može biti supstituiran sa supstituentom odabranim iz skupine koja sadrži C1-C4-alkoksi i C1-C6-alkilamino, igdje C1-C4-alkil može biti supstituiran sa supstituentom odabranim iz skupine koja sadrži halogen, hidroksil, amino, aminokarbonil, C1-C4-alkoksi, C1-C6- alkilamino, C1-C4-alkiltio, C1-C4-alkilkarbonil, C1-C4-alkilkarboniloksi, C1-C4- alkilsulfonil, C1-C4-alkoksikarbonil, C1-C4-alkoksikarbonilamino, C3-C6- cikloalkil, C3-C6-cikloalkilamino, 4- do 6-člani heterociklil, fenil, fenoksi, 5- ili 6-člani heteroaril i 5- ili 6-člani heteroariltio, gdje cikloalkil, heterociklil, fenil, fenoksi, heteroaril i heteroariltio mogu biti supstituirani sa 1 do 3 supstituenta odabrana nezavisno jedan od drugoga iz skupine koja sadrži halogen, cijano, hidroksimetil, monofluorometil, difluorometil, trifluorometil, monofluorometoksi, difluorometoksi, trifluorometoksi, monofluorometilsulfanil, difluorometilsulfanil, trifluorometilsulfanil, C1- C4-alkil, C1-C4-alkoksi, C3-C6-cikloalkil, 4- do 6-člani heterociklil, fenil i 5- ili 6-člani heteroaril, R3 predstavlja C1-C6-alkil, C1-C6-alkoksi, C1-C6-alkilamino, C3-C7-cikloalkil, 4- do 6-člani heterociklil, fenil ili 5- ili 6-člani heteroaril, gdje alkil, C2-C6-alkoksi i alkilamino mogu biti supstituirani sa supstituentom odabranim iz skupine koja sadrži hidroksil, amino, cijano i C1-C4-alkoksi, igdje cikloalkil, heterociklil, fenil i heteroaril mogu biti supstituirani sa 1 do 3 supstit
Patent HR-P20120641-T1 (HR)
Inventor: RICHARD OWEN MANNION
IPC: A61K9/32
Filed: 2012-08-07
Abstract: Oralni farmaceutski oblik doziranja u krutom stanju sa produljenim otpuštanjem koji sadrži formulaciju matrice s produljenim otpuštanjem, koji je stvrdnut na temperaturi od najmanje oko 60 °C tijekom vremenskog perioda od najmanje oko 1 minute, te formulacija matrice s produljenim otpuštanjem sadrži pripravak koji je naznačen time da sadrži barem: najmanje jedan polietilen oksid koji ima, prema reološkim mjerenjima, molekularnu težinu od najmanje 1,000,000; tenajmanje jedno aktivno sredstvo odabrano od opioidnih analgetika; tepri čemu pripravak sadrži barem oko 80 % (težinski) polietilen oksida. Patent sadrži još 40 patentnih zahtjeva.
Patent SI-1409423-T1 (SI)
Title: Method and apparatus for the manufacture of mineral wool
Inventor: ASTRAND ERIK
IPC: C03B37/05
Filed: 2002-07-18
Abstract: The invention relates to a method and an apparatus for the manufacture of mineral wool fibres with a fiberising apparatus comprising rotating rotors, in order to form mineral melt into fibres. The first and second rotors of the fiberising apparatus rotating toward each other form an upper rotor pair, and the fiberising apparatus comprises at least one further rotor, advantageously a rotor pair, which is arranged below the upper rotor pair. Mineral melt is fed from a melting furnace or the like in the form of a melt jet toward a first position on the mantle surface of the first rotor, from where it is thrown out from the mantle surface of the first rotor in the form of a drop cascade toward the mantle surface of the second rotor. A first portion of mineral melt is formed into fibres at the second rotor and blown off the rotor, and a second portion of mineral melt is thrown out from the second rotor in the form of a drop cascade. The main portion of that drop cascade being thrown out from the second rotor is arranged to be thrown toward the mantle surface of the first rotor, toward a second position downstream from said first position on the mantle surface. A portion of mineral melt is formed into fibres at the first rotor and blown off the rotor.
Patent SI-2264019-T1 (SI)
Title: Intermediates for the preparation of taxane derivatives
Inventor: FONTANA GABRIELE
IPC: C07D305/14
Filed: 2003-09-05
Abstract: A process for the preparation of compounds of formula XIV starting from compounds of formula XIII   
wherein 
R 2  is an acyl group or an alcohol-protecting group; 
R 3  is hydrogen, acyl, alkyl or, taken together with R 4 , forms a C=O, C=S, SO, SO 2  group; 
R 4  is hydrogen or, taken together with R 3 , forms a C=O, C=S, SO, SO 2  group; 
R 5  is hydrogen or an alcohol-protecting group; 
R 6  is aryl, substituted aryl, heteroaryl; 
comprising: 
a) selective reduction of the azido group to amino group; 
b) optional treatment with alkylating or acylating agents; 
c) cleavage of the C7 protective group; 
d) opening of the oxazolidine.
Patent SI-1730153-T1 (SI)
Title: Isopropanol water solvate of olanzapine
Inventor: KOTAR-JORDAN BERTA
IPC: C07D495/04
Filed: 2005-03-07
Abstract: The invention relates to a novel and well defined Oolvate form of olanzapine which contains 2 molecules of water and 1 molecule of isopropanol per 2 molecules of olanzapine, and which can be converted into other, forms of olanzapine, in particular form (I) of olanzapine, as well as processes for preparing form (I) olanzapine.
Patent SI-1773902-T1 (SI)
Title: Reactivity drift and catalyst degradation in polyurethane foam
Inventor: SCHULTE MARK S
IPC: C08J9/00
Filed: 2005-07-29
Abstract: The invention is directed to methods of preparing compositions used to manufacture polyurethane foams. The invention provides methods for making compositions used to make polyurethane foams that include amine catalysts, but formulated such that catalytic potency is not diminished over time before the forming of a foam.
Patent SI-2247764-T1 (SI)
Title: Rail steel with an excellent combination of wear properties and rolling contact fatigue resistance
Inventor: CARROLL ROBERT
IPC: C22C38/12
Filed: 2009-02-23
Abstract: A high-strength pearlitic steel rail with an excellent combination of wear properties and rolling contact fatigue resistance wherein the steel has 0.88% to 0.95% carbon, 0.75% to 0.92% silicon, 0.80% to 0.95% manganese, 0.05% to 0.14% vanadium, up to 0.008% nitrogen, up to 0.030% phosphorus, 0.008 to 0.030% sulphur, at most 2.5 ppm hydrogen, at most 0.10% chromium, at most 0.010% aluminium, at most 20 ppm oxygen, the remainder being iron and unavoidable impurities.
Patent TR-200100180-T1 (TR)
Title: Olefin polimer materyalden preslenmiş yüksek yüzey parlaklığı olan tabakalar
Inventor: SHAH BAKHTIAR ALAM
IPC: C08L23/16
Filed: 2000-04-06
Abstract: Bu bulus, olefin polimer materyalden preslenmis tabakalar ile ilgilidir.
Patent TR-201607901-T1 (TR)
Title: Gübre ürünleri.
Inventor: RAKSH VIR JASRA
IPC: C05G3/70
Filed: 2015-01-15
Abstract: Bu bildiri, ilk karışım hazırlanması, harmanlama, karışımın hamur oluşturacak şekilde yoğrulması, hamurun şekilli maddeler oluşturacak şekilde işlemden geçirilmesi ve bu şekillerin anlatılan gübre ürününü oluşturacak şekilde kurutulmasını içeren bir süreç ile ilgilidir. Bu bildirimde açıklanan gübre ürünü, element biçiminde sülfür, en az bir şişirme maddesi, en az bir bağlama maddesi, en az bir bitki büyüme regülatörü ve isteğe bağlı olarak en az bir inorganik madde ve su içermektedir.
Patent DE-3781841-T2 (DE)
Inventor: PRY TERRY ALAN
IPC: G01N33/538
Filed: 1987-07-07
Granted: 1993-04-15
Abstract: A method for performing a diagnostic immunoassay by a solid phase separation. To a reaction mixture of a test sample and labeled antibody, which forms a complex of any analyte present in the test sample, is added a solid phase material having a compound capable of binding any excess labeled antibody. The solid phase material is chosen to rapidly settle whereby a solid and liquid phase is formed. The liquid phase can then be extracted to measure the amount of analyte-labeled antibody present therein.
Patent DE-3785194-T2 (DE)
Inventor: PASCAL CHRISTIAN
IPC: B65D81/127
Filed: 1987-10-12
Granted: 1993-07-15
Abstract: Parallelepipedic packaging made of semi-rigid material or similar, comprised of an element forming an outer shell and two composite elements forming a damping receptacle characterized by a single damping on the side faces and a double damping on the top and bottom faces. The packaging has a variable damping function adapted to the various fragility degrees of different contents, with reinforcement at the positioning points of the bottoms and lids. Said packaging is perfectly adapted to and in conformity with the packaging requirements of dangerous materials and/or materials of which maritime, air or road transportation is controlled by regulations, independently of the nature and mode of preconditioning of said materials, and said packaging comes also within the packaging requirements of all fragile materials or items.
Patent DE-3787467-T2 (DE)
Inventor: TAKEZAWA KEISUKE
IPC: A63F13/833
Filed: 1987-11-13
Granted: 1994-01-13
Abstract: A pneumatic operating device particularly suited for a video boxing game machine in which a displayed boxer is made by a player to fight against an opponent. The device comprises an air chamber (A) whose volume is variable by applying an impact on a slider button (18). The air chamber is connected through a pressure transmission passage (B) to a pressure sensor which (C) detects the pressure variation within the air chamber to produce a corresponding electric signal for controlling the displayed boxer.
Patent DE-3788129-T2 (DE)
Inventor: WIKSELL HANS
IPC: A61B17/32
Filed: 1987-11-20
Granted: 1994-05-26
Abstract: A curved ultrasonic knife consisting of a transducer unit (5) and an amplitude-amplifying horn connected directly thereto, the knife being shaped to imbue the tip (43) of the horn with, to a great extent, purely longitudinal oscillation. The transducer unit includes a piezoelectric unit axially clamped in the transducer unit (5). A resonance rod (28) located between the piezoelectric unit and the horn (2) is bent to give a deflection of 16 DEG , for example.
Patent DE-3854932-T2 (DE)
Inventor: HADLEY MICHAEL STEWART BEECHAM
IPC: C07D453/02
Filed: 1988-04-13
Granted: 1996-06-13
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof: <CHEM> in which X represents R1OOC- in which R1 is C1-4 alkyl, C2-4 alkenyl or C2-4 alkynyl; R2O- in which R2 is C1-2 alkyl, C1-2 alkylcarbonyl or aminocarbonyl optionally substituted by one or two methyl groups;    a group <CHEM> in which Y represents a 3-membered divalent residue completing a 5-membered aromatic ring and comprises one or two heteroatoms selected from oxygen, nitrogen and sulphur, any amino nitrogen optionally substituted by a C1-2 alkyl group, Y being optionally C-substituted by a methyl group; or a group <CHEM> in which A1 is oxygen or sulphur, one of A2 and A3 is CR3 and the other is nitrogen or CR4 where R3 and R4 are independently selected from hydrogen and methyl; and each of p and q independently represents an integer of 2 to 4.
Patent DE-3880419-T2 (DE)
Inventor: LAJOVIC DUSAN SAVA
IPC: B65D5/42
Filed: 1988-09-02
Granted: 1993-08-05
Abstract: A laminated tubular body comprising; an outer layer and an inner layer which contacts the inner surface of the outer layer; wherein the outer layer is penetrated by at least one aperture and the inner layer extends into said at least one aperture.
Patent TR-199801936-T2 (TR)
Title: Linyit kömürünün ufalanmasi ve kurutulmasi için yöntem.
Inventor: KNIZIA MALTE
IPC: C10F5/00
Filed: 1997-03-26
Abstract: Linyit kömürünün (RK) ufalanmasi ve kurutulmasina yarayan yöntem olup, bu yöntemde linyit kömürü, en az iki adet ufalanma safhasindan(2,7) geçirilerek dolayli olarak isitilan girdapli tabaka kurutucusunda (9) kurutulur, bu arada en az bir ufalama safhasi girdapli tabaka kurutmasindan evvel yapilir ve girdapli tabaka kurutmasinda bir toz ayirici (14) vasitasiyla buhar bulutlari alinir, ufalama masrafinin düsük olmasi için, girdapli tabaka kurutmasinin (9) buhar bulutlari (B),elenmis ufalanmis linyit kömürünün (3) elek buhari (4) olarak kullanilip bu elemenin geride kalani baska ufalanmaya tabi tutulmaz.